Targets and candidate agents for Type 2 diabetes treatment with computational bioinformatics approach

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Wang, Qiong ^a   Zhao, Zhigang ^a   Shang, Jing ^a   Xia, Wei ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; COMPLEMENT; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 7; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN; SELENIUM; TRANSCRIPTION FACTOR; BENZOPHENANTHRIDINE DERIVATIVE; ISOQUINOLINE DERIVATIVE; SANGUINARINE; THIORPHAN;

ARTICLE; BIOINFORMATICS; CELL METABOLISM; CELL SURFACE; FATTY ACID OXIDATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOLECULE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM; BIOLOGY; COMPUTER AIDED DESIGN; DIABETES MELLITUS, TYPE 2; DRUG DESIGN; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY;

BENZOPHENANTHRIDINES; COMPUTATIONAL BIOLOGY; COMPUTER-AIDED DESIGN; DATABASES, GENETIC; DIABETES MELLITUS, TYPE 2; DRUG DESIGN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; ISOQUINOLINES; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; THIORPHAN;

EID: 84911166972     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/763936     Document Type: Article

References (50)

1. Defronzo R. A., From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009 58 4 773 795 10.2337/db09-9028 2-s2.0-64649104158
2. DeFronzo R. A., Pharmacologic therapy for type 2 diabetes mellitus. Annals of Internal Medicine 1999 131 4 281 303 10.7326/0003-4819-131-4-199908170-00008 2-s2.0-0033578476
3. Tuomilehto J., Lindström J., Eriksson J. G., Valle T. T., Hamäläinen H., Ianne-Parikka P., Keinänen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine 2001 344 18 1343 1350 10.1056/NEJM200105033441801 2-s2.0-0035799806
4. Taneera J., Lang S., Sharma A., Fadista J., Zhou Y., Ahlqvist E., Jonsson A., Lyssenko V., Vikman P., Hansson O., Parikh H., Korsgren O., Soni A., Krus U., Zhang E., Jing X.-J., Esguerra J. L. S., Wollheim C. B., Salehi A., Rosengren A., Renström E., Groop L., A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metabolism 2012 16 1 122 134 10.1016/j.cmet.2012.06.006 2-s2.0-84863516095
5. Tuomilehto J., Wolf E., Primary prevention of diabetes mellitus. Diabetes Care 1987 10 2 238 248 10.2337/diacare.10.2.238 2-s2.0-0023221765
6. Hamman R. F., Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes/Metabolism Reviews 1992 8 4 287 338 10.1002/dmr.5610080402 2-s2.0-0026969347
7. Manson J. E., Rimm E. B., Stampfer M. J., Colditz G. A., Willett W. C., Krolewski A. S., Rosner B., Hennekens C. H., Speizer F. E., Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. The Lancet 1991 338 8770 774 778 10.1016/0140-6736(91)90664-B 2-s2.0-0025786948
8. Grant S. F. A., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K. P., Walters G. B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R. L., Reilly M. P., Rader D. J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J. R., Kong A., Stefansson K., Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 2006 38 3 320 323 10.1038/ng1732 2-s2.0-32544451924
9. Stumvoll M., Goldstein B. J., van Haeften T. W., Type 2 diabetes: principles of pathogenesis and therapy. The Lancet 2005 365 9467 1333 1346 10.1016/S0140-6736(05)61032-X 2-s2.0-17044386953
10. Butler A. E., Janson J., Bonner-Weir S., Ritzel R., Rizza R. A., Butler P. C., β -cell deficit and increased β -cell apoptosis in humans with type 2 diabetes. Diabetes 2003 52 1 102 110 10.2337/diabetes.52.1.102 2-s2.0-0037219411
11. Meier J. J., Bonadonna R. C., Role of reduced β -cell mass versus impaired β -cell function in the pathogenesis of type 2 diabetes. Diabetes Care 2013 36 2 S113 S119 10.2337/dcS13-2008 2-s2.0-84890494543
12. Sean D., Meltzer P. S., GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 2007 23 14 1846 1847 10.1093/bioinformatics/btm254 2-s2.0-34547871639
13. Diboun I., Wernisch L., Orengo C. A., Koltzenburg M., Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 2006 7, article 252 10.1186/1471-2164-7-252 2-s2.0-33750616076
14. Smyth G. K., Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 2004 3 article 3 10.2202/1544-6115.1027 MR2101454
15. Team R. D. C., R: A Language and Environment for Statistical Computing 2005 Vienna, Austria R Foundation for Statistical Computing. http://www.R-project.org
16. Yekutieli D., Benjamini Y., Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics. Journal of Statistical Planning and Inference 1999 82 1-2 171 196 10.1016/S0378-3758(99)00041-5 MR1736442 2-s2.0-0033472709
17. Kelder T., van Iersel M. P., Hanspers K., Kutmon M., Conklin B. R., Evelo C. T., Pico A. R., WikiPathways: building research communities on biological pathways. Nucleic Acids Research 2012 40 1 D1301 D1307 10.1093/nar/gkr1074 2-s2.0-84862203775
18. Duncan D., Prodduturi N., Zhang B., WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 2010 11 supplement 4 P10 10.1186/1471-2105-11-S4-P10
19. Liberzon A., Subramanian A., Pinchback R., Thorvaldsdóttir H., Tamayo P., Mesirov J. P., Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011 27 12 1739 1740 btr260 10.1093/bioinformatics/btr260 2-s2.0-79958135926
20. Lamb J., Crawford E. D., Peck D., Modell J. W., Blat I. C., Wrobel M. J., Lerner J., Brunet J.-P., Subramanian A., Ross K. N., Reich M., Hieronymus H., Wei G., Armstrong S. A., Haggarty S. J., Clemons P. A., Wei R., Carr S. A., Lander E. S., Golub T. R., The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006 313 5795 1929 1935 10.1126/science.1132939 2-s2.0-33749335282
21. Harizi H., Corcuff J.-B., Gualde N., Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends in Molecular Medicine 2008 14 10 461 469 10.1016/j.molmed.2008.08.005 2-s2.0-52949153587
22. Majerus P. W., Arachidonate metabolism in vascular disorders. The Journal of Clinical Investigation 1983 72 5 1521 1525 10.1172/JCI111110 2-s2.0-0021022903
23. Patrignani P., Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease. Thrombosis Research 2003 110 5-6 281 286 10.1016/S0049-3848(03)00382-7 2-s2.0-0142195896
24. Stenson W. F., Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scandinavian Journal of Gastroenterology, Supplement 1990 25 172 13 18 2-s2.0-0024994816
25. Rask-Madsen J., Eicosanoids and their role in the pathogenesis of diarrhoeal diseases. Clinics in Gastroenterology 1986 15 3 545 566 2-s2.0-0022903351
26. Vinik A. I., Erbas T., Sun Park T., Nolan R., Pittenger G. L., Platelet dysfunction in type 2 diabetes. Diabetes Care 2001 24 8 1476 1485 10.2337/diacare.24.8.1476 2-s2.0-0035433149
27. Wolfe L. S., Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. Journal of Neurochemistry 1982 38 1 1 14 10.1111/j.1471-4159.1982.tb10847.x 2-s2.0-0020040981
28. Okumura M., Imanishi M., Yamashita T., Yamamura Y., Kim S., Iwao H., Tanaka S., Fujii S., Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes. Life Sciences 1999 66 5 371 377 10.1016/S0024-3205(99)00603-7 2-s2.0-0033579331
29. Kimple M. E., Keller M. P., Rabaglia M. R., Pasker R. L., Neuman J. C., Truchan N. A., Brar H. K., Attie A. D., Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. Diabetes 2013 62 6 1904 1912 10.2337/db12-0769 2-s2.0-84878231693
30. Unsöld C., Hyytiäinen M., Bruckner-Tuderman L., Keski-Oja J., Latent TGF- β binding protein LTBP-1 contains three potential extracellular matrix interacting domains. Journal of Cell Science 2001 114 1 187 197 2-s2.0-0035153291
31. Jenkins G., The role of proteases in transforming growth factor- β activation. International Journal of Biochemistry and Cell Biology 2008 40 6-7 1068 1078 10.1016/j.biocel.2007.11.026 2-s2.0-43049146157
32. Köppel H., Riedl E., Braunagel M., Sauerhoefer S., Ehnert S., Godoy P., Sternik P., Dooley S., Yard B. A., L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF- β production and signalling. Nephrology Dialysis Transplantation 2011 26 12 3852 3858 10.1093/ndt/gfr324 2-s2.0-82255185487
33. Pscherer S., Freude T., Forst T., Nussler A. K., Braun K. F., Ehnert S., Anti-diabetic treatment regulates pro-fibrotic TGF- β serum levels in type 2 diabetics. Diabetology and Metabolic Syndrome 2013 5 1, article 48 10.1186/1758-5996-5-48 2-s2.0-84883175084
34. + T cells through TGF- β -TGF- β receptor interactions in type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America 2003 100 19 10878 10883 10.1073/pnas.1834400100 2-s2.0-0141703239
35. Schuit F., van Lommel L., Granvik M., Goyvaerts L., de Faudeur G., Schraenen A., Lemaire K., β -cell-specific gene repression: a mechanism to protect against inappropriate or maladjusted insulin secretion? Diabetes 2012 61 5 969 975 10.2337/db11-1564 2-s2.0-84860584838
36. Hu P., Margolis B., Skolnik E. Y., Lammers R., Ullrich A., Schlessinger J., Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Molecular and Cellular Biology 1992 12 3 981 990 2-s2.0-0026537450
37. Hayashi H., Nishioka Y., Kamohara S., Kanai F., Ishii K., Fukui Y., Shibasaki F., Takenawa T., Kido H., Katsunuma N., Ebina Y., The α -type 85-kDa subunit of phosphatidylinositol 3-kinase is phosphorylated at tyrosines 368, 580, and 607 by the insulin receptor. Journal of Biological Chemistry 1993 268 10 7107 7117 2-s2.0-0027405017
38. Zhang Y., Wolf-Yadlin A., Ross P. L., Pappin D. J., Rush J., Lauffenburger D. A., White F. M., Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Molecular and Cellular Proteomics 2005 4 9 1240 1250 10.1074/mcp.M500089-MCP200 2-s2.0-26844576371
39. Xu J.-Y., Meng Q.-H., Chong Y., Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Molecular and Clinical Oncology 2013 1 2 331 336
40. Mackraj I., Govender T., Gathiram P., Sanguinarine. Cardiovascular Therapeutics 2008 26 1 75 83 10.1111/j.1527-3466.2007.00037.x 2-s2.0-47049121012
41. Choi W. Y., Jin C.-Y., Han M. H., Kim G.-Y., Kim N. D., Lee W. H., Kim S.-K., Choi Y. H., Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Anticancer Research 2009 29 11 4457 4465 2-s2.0-75149114612
42. Park H., Bergeron E., Senta H., Guillemette K., Beauvais S., Blouin R., Sirois J., Faucheux N., Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways. Biochemical and Biophysical Research Communications 2010 399 3 446 451 10.1016/j.bbrc.2010.07.114 2-s2.0-77956178441
43. Sun M., Lou W., Chun J. Y., Cho D. S., Nadiminty N., Evans C. P., Chen J., Yue J., Zhou Q., Gao A. C., Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. Genes and Cancer 2010 1 3 283 292 10.1177/1947601910368849 2-s2.0-79952842078
44. Tsukamoto H., Kondo S., Mukudai Y., Nagumo T., Yasuda A., Kurihara Y., Kamatani T., Shintani S., Evaluation of anticancer activities of benzo[c]phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line. Anticancer Research 2011 31 9 2841 2846 2-s2.0-80051655844
45. Jang B.-C., Park J.-G., Song D.-K., Baek W.-K., Yoo S. K., Jung K.-H., Park G.-Y., Lee T.-Y., Suh S.-I., Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicology in Vitro 2009 23 2 281 287 10.1016/j.tiv.2008.12.013 2-s2.0-59449083445
46. Sun M., Liu C., Nadiminty N., Lou W., Zhu Y., Yang J., Evans C. P., Zhou Q., Gao A. C., Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. The Prostate 2012 72 1 82 89 10.1002/pros.21409 2-s2.0-81855185596
47. Chauhan A., Sharma P., Srivastava P., Kumar N., Dudhe R., Plants having potential antidiabetic activity: a review. Der Pharmacia Lettre 2010 2 3 369 387
48. Jerjomiceva N., Exploring Natural and Pharmocological Products for the Ability to Boost Neutrophils Against Bacterial Infections 2013 Hannover, Germany Tierärztliche Hochsch
49. Muangman P., Tamura R. N., Gibran N. S., Antioxidants inhibit fatty acid and glucose-mediated induction of neutral endopeptidase gene expression in human microvascular endothelial cells. Journal of the American College of Surgeons 2005 200 2 208 215 10.1016/j.jamcollsurg.2004.09.043 2-s2.0-12444257014
50. Antezana M. A., Sullivan S. R., Usui M. L., Gibran N. S., Spenny M. L., Larsen J. A., Ansel J. C., Bunnett N. W., Olerud J. E., Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. Journal of Investigative Dermatology 2002 119 6 1400 1404 10.1046/j.1523-1747.2002.19618.x 2-s2.0-0036906956